M14-433
ClinicalTrials.gov NCT03345823
Research payments
$3,763,755
Through program year 2020, $3,763,755 in research payments was reported against M14-433, across 632 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03345823
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $2,355,127 | 388 |
| 2019 | Research | $1,408,627 | 244 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Esther Torres San Juan, PR Named on 23 payments
- George Duvall Vero Beach, FL Named on 22 payments
- Gerald Dryden Louisville, KY Named on 21 payments
- Jonathan Siegel Mobile, AL Named on 21 payments
- Themistoe Dassopoulos Dallas, TX Named on 20 payments
- Edward Loftus Rochester, MN Named on 20 payments
- John Ferry Omaha, NE Named on 19 payments
- Suzy Kim Greenville, SC Named on 16 payments
- Shahriar Sedghi Macon, GA Named on 16 payments
- Sara Horst Nashville, TN Named on 16 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.